CNS Pharmaceuticals(CNSP)
0.2441 0.0007 0.2876%
| 今开：0.261 | 昨收：0.2434 |
| 最高：0.261 | 最低：0.232 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2595987.0 |
CNS Pharmaceuticals的热门讨论
当期报告
CNS Pharmaceuticals(CNSP)04-15 18:15
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359 Act: 34 Size: 4 MB 网页链接查看全文
股东委托书协议
CNS Pharmaceuticals(CNSP)04-10 18:05
$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-002244 Act: 34 Size: 1 MB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002284 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002285 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002288 Size: 7 KB 网页链接查看全文
持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002289 Size: 7 KB 网页链接查看全文
CNS Pharmaceuticals的最新讨论
产业链观察2021-06-30 05:34
药闻| 2021年6月29日, 专门开发针对脑部原发性和转移性癌症的新疗法和中枢神经系统d的生物制药公司$CNS Pharmaceuticals(CNSP)$ 今天宣布美国食品和药物管理局 (FDA) 为其主要研究药物 Berubicin 授予快速通道指定，用于治疗复发性多形性胶质母细胞瘤 (GBM) 适应症。查看全文
修炼中的Jessie2021-02-10 21:15
赛选几轮后，Mark一下建仓的药股们，剩下的就留给时间吧。$CNS Pharmaceuticals(CNSP)$ $Applied Genetic(AGTC)$ $Surface Oncology(SURF)$ VXRT查看全文
![[捂脸]](http://js.xueqiu.com/ugc/images/face/emoji_33_face.png?v=1 "[捂脸]"){kind=small}
![[为什么]](http://js.xueqiu.com/ugc/images/face/emoji_14_doubt.png?v=1 "[为什么]"){kind=small}
![[斜眼]](http://js.xueqiu.com/ugc/images/face/emoji_61_xieyan.png?v=1 "[斜眼]"){kind=small}
哈哈哈，别到时候bxrx那样崩了呀![[抠鼻]](http://js.xueqiu.com/ugc/images/face/emoji_24_nose.png?v=1 "[抠鼻]"){kind=small}
CNS Pharmaceuticals的公告
招股说明书
$CNS Pharmaceuticals(CNSP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-23-008734 Act: 33 Size: 1 MB 网页链接
生效批准
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003505 Act: 33 Size: 1 KB 网页链接
招股说明书
$CNS Pharmaceuticals(CNSP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-23-008578 Act: 33 Size: 103 KB 网页链接
员工持股计划
$CNS Pharmaceuticals(CNSP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001683168-23-008407 Act: 33 Size: 59 KB 网页链接
增发股票注册声明
$CNS Pharmaceuticals(CNSP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-23-008367 Act: 33 Size: 185 KB 网页链接
当期报告
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-23-008159 Act: 34 Size: 235 KB 网页链接
季度财报
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-23-008144 Act: 34 Size: 2 MB 网页链接
当期报告
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 7.01 Accession Number: 0001683168-23-007238 Act: 34 Size: 201 KB 网页链接
当期报告
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001683168-23-007207 Act: 34 Size: 449 KB 网页链接
持股变动声明「修正」
$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-007107 Size: 5 KB 网页链接